Contineum Therapeutics Inc (CTNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,822 | -32,030 | -15,990 | -42,258 | -27,693 |
| Depreciation Amortization | 238 | 157 | 78 | 258 | 183 |
| Accounts payable and accrued liabilities | -1,031 | 190 | 1,834 | 1,141 | 763 |
| Other Working Capital | -5,308 | -3,016 | -1,082 | 5,334 | 2,384 |
| Other Operating Activity | 8,653 | 4,626 | 748 | 2,680 | 1,720 |
| Operating Cash Flow | $-42,270 | $-30,073 | $-14,412 | $-32,845 | $-22,643 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 43,929 | 28,890 | 14,962 | -69,245 | -60,023 |
| PPE Investments | -189 | -91 | -47 | -494 | -328 |
| Investing Cash Flow | $43,740 | $28,799 | $14,915 | $-69,739 | $-60,351 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,476 | 291 | 24 | 109,001 | 108,359 |
| Other Financing Activity | -256 | -176 | 0 | 0 | 0 |
| Financing Cash Flow | $19,220 | $115 | $24 | $109,001 | $108,359 |
| Beginning Cash Position | 21,943 | 21,943 | 21,943 | 15,526 | 15,526 |
| End Cash Position | 42,633 | 20,784 | 22,470 | 21,943 | 40,891 |
| Net Cash Flow | $20,690 | $-1,159 | $527 | $6,417 | $25,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,270 | -30,073 | -14,412 | -32,845 | -22,643 |
| Capital Expenditure | -189 | -91 | -47 | -514 | -348 |
| Free Cash Flow | -42,459 | -30,164 | -14,459 | -33,359 | -22,991 |